Egalet Ltd. (Westminster, UK) is a specialty pharmaceutical company focusing on developing safe, effective, and tamper-resistant medications to address the growing issue of pain medication abuse. 

The company uses its proprietary technology to produce novel therapeutics – both on its own and with partners. Egalet’s pipeline of tamper-resistant opioids are in late clinical development.

For more information, please contact:

Peter Benson, MSc

Chairman & General Partner

Phone: +45 4080 4869